Introduction: The Chikungunya virus (CHIKV), transmitted via mosquitoes, exhibits clinical manifestations ranging from headaches, myalgia and arthralgia to debilitating systemic malfunctions. Endemic to Africa, CHIKV has seen an increase in cases since it was first recorded in 1950. There has recently been an outbreak in numerous African nations. The authors aim to review the history and epidemiology of CHIKV in Africa, current outbreaks, strategies adopted by governments and/or international organisations to mitigate such an outbreak, and future recommendations that can be employed. Methodology: Data were collected from medical journals published on Pubmed and Google Scholar, and from the official World Health Organisation, African and United States of America’s Centres for Disease Control and Prevention websites. All articles considering CHIKV in Africa, including epidemiology, aetiology, prevention and management, were sought after. Results: Since 2015, the number of Chikungunya cases in Africa has increased, reaching the highest values ever recorded, especially in 2018 and 2019. Even though numerous vaccination and therapeutic intervention trials are still ongoing, no advancement has been made so far, including drug approval. Current management is supportive, with preventative measures, such as insecticides, repellents, mosquito nets and habitat avoidance, paramount to halting disease spread. Conclusion: In light of the recent CHIKV outbreak in Africa, local and global attempts are re-emerging to mitigate the eruption of the case of the lack of vaccines and antivirals, controlling the virus may be an arduous feat. Improving risk assessment, laboratory detection and research facilities should be a priority.

This article delves into the interplay of neglected tropical diseases (NTDs) and Sustainable Development Goals (SDGs) within Africa, spotlighting gender disparities in NTD programs. NTDs, impacting marginalized communities, impose considerable physical, mental, and social burdens. The article underscores NTDs as equity markers for SDGs, spotlighting gender‐based imbalances in disease susceptibility, treatment accessibility, and health‐seeking tendencies. Gender's influence on NTD risks is elucidated, emphasizing the heightened susceptibility of women due to socioeconomic constraints, cultural dynamics, and gender norms. The article also highlights the absence of gender considerations in NTD programs, advocating for gender‐integrated strategies, enhanced data collection, and collaborative partnerships to rectify these inequities. By embracing a gender‐equity approach, the article underscores the necessity of gender‐balanced NTD efforts for comprehensive health, sustainable development, and gender parity, demanding cohesive actions across sectors.

This research paper analyses the management and prevention of pre-eclampsia in Nigeria. Although efforts have been made to reduce outcomes due to pre-eclampsia, it still rears its head in the form of high maternal and perinatal morbidity and mortality. The aim of this review was to identify the main obstacles, gaps, and interventions related to the prevention and management of pre-eclampsia in order to be fully knowledgeable of the magnitude of the issue at the national level, to assess if current government policies are adequate and to recommend solutions. A search was performed on online databases and it was completed with hand searches related to the subject matter. Screening tests for early detection of pre-eclampsia are hardly available in Nigeria as many hospitals rely on the history of previous and current pregnancies, blood pressure monitoring and urinalysis–proteinuria. The administration of low-dose aspirin, antihypertensive drugs and magnesium sulphate, coupled with calcium in calcium deficit regions, was recommended. The main barriers to the wider implementation of these strategies are inadequacy of the antenatal care services in providing appropriate care, lack of resources and trained personnel, high healthcare costs, and low antennal care attendance. Improving education and awareness, use of low-cost screening modalities and low-dose aspirin can be deployed in developing countries to curb pre-eclampsia.

The increasing rate of opioid consumption among Nigerian students is alarming. Despite the therapeutic benefits of opioids, their excessive use could be detrimental. Exploring knowledge gaps and implementing preventive strategies are necessary to curb opioid misuse among Nigerian students. This review aimed to identify the prevalence estimates of non-prescribed opioid use among Nigerian students and explore the cultural and societal factors favoring opioid and other drug use in this population. It further aimed to provide and discuss strategies that could offer effective and long-lasting solutions for Nigerian policymakers to curb opioid use among Nigerian students. A systematic search strategy identified relevant studies from databases such as PubMed and Google Scholar using keywords such as opioid misuse, students, Nigeria, prevention strategies, and opioid use disorder. Articles on the prevalence rates, associated factors, and preventive measures were extracted. The findings revealed a high prevalence of opioid use among Nigerian students, particularly in the southwestern (7.87%) and northeastern (6.57%) parts of Nigeria. Approximately 4.6 million Nigerians, constituting 4.7% of the population, have used opioids for non-medical purposes. Tramadol and codeine are the most commonly misused opioids. Cultural practices and belief systems often impact the knowledge, attitudes, and perceptions of opioid use among students. Efforts to prevent and control opioid misuse in Nigeria should focus on effective coordination among students. Health-promotion measures and specific protection should be promoted alongside early diagnosis, prompt treatment, and rehabilitation of affected individuals.